The funded Influenza Immunisation Programme runs from 18 March through 31 December in 2020
INFLUVAC® TETRA or AFLURIA® QUAD – for adults and children aged 3 years or older
AFLURIA® QUAD JUNIOR – for children aged under 3 years, i.e. 6–35 months
Eligibility criteria for FREE seasonal influenza vaccination for 2020:
Pregnant women (any trimester)
People aged 65 years and older
People aged under 65 years with any of the medical conditions listed below
Children aged 4 years or under who have been hospitalised for respiratory illness or have a history of significant respiratory illness
The following conditions are excluded from funding:
- asthma not requiring regular preventative therapy
- hypertension and/or dyslipidaemia without evidence of end-organ disease
Eligible medical conditions for funded influenza vaccine
List of eligible medical conditions for free influenza immunisation (adults and children).
Funded influenza vaccine is available each year for patients who meet
• all people 65 years of age and over; or
• people under 65 years of age who:
• have any of the following other conditions:
• autoimmune disease(b), or
Unless meeting the criteria set out above, the following conditions are
• asthma not requiring regular preventative therapy,
Also refer to the New Zealand Pharmaceutical Schedule on the PHARMAC website https://www.pharmac.govt.nz/tools-resources/pharmaceutical-schedule/community/
|#Influenza vaccination precaution
Influenza vaccination may be contraindicated or need to be delayed for people receiving some new cancer treatments. Please read the information under Contraindications and precautions to receiving influenza vaccine on page 16 of the Flu Kit Booklet 2020 for people receiving atezolizumab (TECENTRIQ®), ipilimumab (YERVOY®), nivolumab (OPDIVO®) and pembrolizumab (KEYTRUDA®) and contact the person’s oncologist or 0800 IMMUNE (0800 466 863) for current advice about influenza vaccination for these people BEFORE administering the vaccine.
a. Chronic respiratory diseases may include: chronic bronchitis, chronic obstructive pulmonary disease, cystic fibrosis, emphysema.